The goal of this study is to evaluate the role of simulation in the development of technical surgical skills.

This study intends to examine how Black, queer, and disabled individuals navigate risk assessments in a "post-pandemic" era and how this may impact their interpersonal relationships and trust in the authority and credibility of the CDC.

To create digital tools to support young adult cancer survivors completing active treatment and transitioning into survivorship care.

This mixed methods study aims to better understand parents' decisions in the Southeast United States who send their children to ACE and non-ACE preschool programs by exploring their characteristics and motivations for enrolling their young children in these programs.

This study seeks to determine the best practices for boosting the Mobile Crisis Workforce in Illinois. Right now, there is a massive shortage of people to help during mental health crises, and it is very important that we figure out how to fix this issue.

To establish the efficacy of Collagen X Biomarker (CXM) as a measure of growth activity and velocity compared to the current radiographic and anthropometric measures in children with idiopathic scoliosis.

This study explores how older adults interact with ChatGPT, an AI-driven text generation platform. The research aims to identify usability challenges, examine the influence of prior technology experience, and understand factors that encourage or hinder long-term use of AI tools in this demographic.

]We are conducting a study to better understand individuals' pain experiences during IUD insertion. The goal of our study is to learn more about these experiences so that we can work to improve patient care.

We want to create a registry of new and established patients with Keratoconus who attend the UNC Department of Ophthalmology, with the aim of understanding risk factors, how the disease develops and response to treatment.

This phase 3 trial compares the effect of selumetinib versus the standard of care treatment with carboplatin and vincristine (CV) in treating patients with newly diagnosed or previously untreated low-grade glioma (LGG) that does not have a genetic abnormality called BRAFV600E mutation and is not associated with systemic neurofibromatosis type 1. Selumetinib works by blocking some of the enzymes needed for cell growth and may kill tumor cells. Carboplatin and vincristine are chemotherapy drugs that work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. The overall goal of this study is to see if selumetinib works just as well as the standard treatment of CV for patients with LGG. Another goal of this study is to compare the effects of selumetinib versus CV in subjects with LGG to find out which is better. Additionally, this trial will